menu

NEWS

  • Nob. 15, 2018
  • Sep. 30, 2018
    NapaJen Pharma, Co., Ltd. presents 2 posters at Oligonucleotide Therapeutics Society (OTS 2018)
  • May. 18, 2018
    NapaJen Pharma, Inc. Closes US$1 Million Series B-1 Financing
  • Feb. 09, 2018
    NapaJen Pharma Co., Ltd established an Australian subsidiary
  • Dec. 07, 2016
    NapaJen Pharma, Inc. Closes US$14.5 Million Series B Financing
  • Dec. 01, 2016
    NapaJen Pharma, Inc. Appoints Kenji Arima new CDO
  • Apr. 22, 2016
    NapaJen Pharma, Inc. Submitted pre-IND Package to FDA
  • Feb. 03, 2014
    NapaJen Pharma, Inc. Closes US$10 Million Series A-1 Financing